Edwards Lifesciences to Acquire Innovalve
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
BTIG Reiterates Neutral Rating on Edwards Lifesciences (EW)
July 15, 2024 1:24 PM EDTBTIG analyst Marie Thibault reiterated a Neutral rating on Edwards Lifesciences (NYSE: EW).
The analyst comments "Edwards Lifesciences announced this morning that it exercised its option to acquire Innovalve Bio Medical (Private), an early-stage transcatheter mitral valve replacement (TMVR) company that EW made an initial investment into in 2017. EW... More
